| RS1218728112 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1218732639 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1218736157 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Walker-Warburg congenital muscular dystrophy |
| RS1218755350 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS1218757887 |
MESP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1218807903 |
OTOG
|
Health Risk |
Pathogenic |
— |
| RS1218815001 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS1218815157 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1218848193 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1218856350 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS1218859102 |
DDB2
|
Health Risk |
Pathogenic |
— |
| RS1218867675 |
PEX19
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 12A (Zellweger), Peroxisome biogenesis disorder 12A (Zellweger) |
| RS1218883375 |
FSIP2
|
Health Risk |
Pathogenic |
Spermatogenic failure 34, Spermatogenic failure 34 |
| RS1218889239 |
LAMB2
|
Health Risk |
Pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS1218912028 |
TERB2
|
Health Risk |
Pathogenic |
Spermatogenic failure 59, Spermatogenic failure 59 |
| RS1218912272 |
FLG
|
Health Risk |
Pathogenic |
8 conditions, 8 conditions |
| RS1218918142 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1218945005 |
PBX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS1218962425 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1218976308 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS1218997631 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS1219000676 |
EFTUD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1219026826 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1219040737 |
KIDINS220
|
Health Risk |
Likely pathogenic |
— |
| RS1219047251 |
CRB2
|
Health Risk |
Likely pathogenic |
CRB2-related disorder, CRB2-related disorder |
| RS1219060764 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS121907888 |
GNMT
|
Health Risk |
Pathogenic |
Glycine N-methyltransferase deficiency, Glycine N-methyltransferase deficiency |
| RS121907892 |
SLC22A12
|
Health Risk |
Pathogenic |
Dalmatian hypouricemia, SLC22A12-related disorder |
| RS121907893 |
SLC22A12
|
Health Risk |
Pathogenic/Likely pathogenic |
Dalmatian hypouricemia, Dalmatian hypouricemia |
| RS121907894 |
SLC22A12
|
Health Risk |
Pathogenic |
Dalmatian hypouricemia, Dalmatian hypouricemia |
| RS121907895 |
SLC22A12
|
Health Risk |
Pathogenic |
Dalmatian hypouricemia, Dalmatian hypouricemia |
| RS121907896 |
SLC22A12
|
Health Risk |
Pathogenic |
Dalmatian hypouricemia, Familial renal hypouricemia |
| RS121907897 |
SLC22A12
|
Health Risk |
Pathogenic |
Dalmatian hypouricemia, Dalmatian hypouricemia |
| RS121907898 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis 1, Nephronophthisis |
| RS121907899 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis 1, Nephronophthisis |
| RS121907900 |
WT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Drash syndrome, Nephrotic syndrome |
| RS121907901 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Wilms tumor 1 |
| RS121907902 |
WT1
|
Health Risk |
Likely pathogenic |
Drash syndrome, Frasier syndrome |
| RS121907903 |
WT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Drash syndrome, WT1-related disorder |
| RS121907904 |
WT1
|
Health Risk |
Likely pathogenic |
Drash syndrome, Leber congenital amaurosis 10 |
| RS121907905 |
WT1
|
Health Risk |
Likely pathogenic |
Drash syndrome, Frasier syndrome |
| RS121907906 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Wilms tumor 1 |
| RS121907907 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS121907908 |
WT1
|
Health Risk |
Pathogenic |
Mesothelioma, Mesothelioma |
| RS121907909 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, Frasier syndrome |
| RS121907910 |
WT1
|
Health Risk |
Pathogenic |
Meacham syndrome, Nephrotic syndrome |
| RS121907911 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS121907912 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS121907913 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, ANTERIOR SEGMENT DYSGENESIS 5 |
| RS121907914 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS121907915 |
PAX6
|
Health Risk |
Pathogenic |
Cataracts, congenital |
| RS121907916 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS121907917 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS121907918 |
PAX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Foveal hypoplasia 1, Aniridia 1 |
| RS121907919 |
PAX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aniridia, atypical |
| RS121907920 |
PAX6
|
Health Risk |
Pathogenic |
Foveal hypoplasia 1 with cataract, Aniridia 1 |
| RS121907921 |
PAX6
|
Health Risk |
Pathogenic |
ANTERIOR SEGMENT DYSGENESIS 5, MULTIPLE SUBTYPES |
| RS121907922 |
PAX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aniridia 1, Visual impairment |
| RS121907923 |
PAX6
|
Health Risk |
Pathogenic |
Coloboma of optic nerve, Coloboma of optic nerve |
| RS121907924 |
PAX6
|
Health Risk |
Pathogenic |
Isolated optic nerve hypoplasia, Irido-corneo-trabecular dysgenesis |
| RS121907925 |
PAX6
|
Health Risk |
Pathogenic |
Coloboma, ocular |
| RS121907926 |
PAX6
|
Health Risk |
Pathogenic |
Optic nerve aplasia, bilateral |
| RS121907927 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS121907928 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS121907929 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS121907930 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS121907931 |
ALG12
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation |
| RS121907932 |
ALG12
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-related disorder |
| RS121907933 |
ALG12
|
Health Risk |
Likely pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-related disorder |
| RS121907934 |
ALG12
|
Health Risk |
Pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation |
| RS121907935 |
ALG12
|
Health Risk |
Pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation |
| RS121907936 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS121907937 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS121907938 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS121907939 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS121907940 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS121907941 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS121907942 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS121907943 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS121907945 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS121907946 |
GCLC
|
Health Risk |
Pathogenic |
Gamma-glutamylcysteine synthetase deficiency, Gamma-glutamylcysteine synthetase deficiency |
| RS121907947 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary C1 esterase inhibitor deficiency - dysfunctional factor, Hereditary C1 esterase inhibitor deficiency - dysfunctional factor |
| RS121907948 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary C1 esterase inhibitor deficiency - dysfunctional factor, Hereditary angioedema type 1 |
| RS121907949 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary C1 esterase inhibitor deficiency - dysfunctional factor, Hereditary C1 esterase inhibitor deficiency - dysfunctional factor |
| RS121907951 |
SERPING1
|
Health Risk |
Pathogenic |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS121907952 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Inborn genetic diseases |
| RS121907953 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, B1 variant |
| RS121907954 |
HEXA
|
Health Risk |
Likely pathogenic |
Gm2-gangliosidosis, adult |
| RS121907955 |
HEXA
|
Health Risk |
Pathogenic/Likely pathogenic |
GM2-GANGLIOSIDOSIS, JUVENILE |
| RS121907956 |
HEXA
|
Health Risk |
Pathogenic |
GM2-GANGLIOSIDOSIS, JUVENILE |
| RS121907957 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Glioma susceptibility 1 |
| RS121907958 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS121907959 |
HEXA
|
Health Risk |
Pathogenic/Likely pathogenic |
TAY-SACHS DISEASE, JUVENILE |
| RS121907960 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Inborn genetic diseases |
| RS121907961 |
HEXA
|
Health Risk |
Pathogenic/Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS121907962 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS121907963 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS121907964 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS121907965 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS121907966 |
HEXA
|
Health Risk |
Pathogenic |
GM2-gangliosidosis, adult-onset |